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SUMMARY

We determined cytokines (e.g. interleukin-8, 10, 12 and TNF-α) expression by peripheral blood mononuclear cells
(PBMCs) and in rectal mucosa in diarrhoea-predominant irritable bowel syndrome (D-IBS) with Blastocystis spp. Eighty
patients with D-IBS and Blastocystis spp. infection were classiﬁed as ‘cases’ and 80 with D-IBS without Blastocystis spp.
infection were classiﬁed as ‘control’. Cases were subdivided into D-IBS and Blastocystis sp. deﬁned type 1 (subtype-speciﬁc
primer SB83) and type 3 (SB227). Stool microscopy and culture were performed. Rectal biopsies were obtained for
histology and cytokines by real-time PCR for mRNA expression of cytokines. PBMCs IL-8 was similar in diﬀerent groups
but in type 1, IL-8mRNA was increased compared with type 3 (P = 0·001) and control (P = 0·001). In type 1, IL-10 by
PBMCs had a low mean value (14·5 ± 1·6) compared with (16·7 ± 1·5) type 3 and (16 ± 2·3) in controls (P < 0·001 and
P < 0·001, respectively). In Blastocystis sp. type 1, low IL-10 was associated with lymphocyte and plasma cell inﬁltration
(P = 0·015 and P = 0·002, respectively). In Blastocystis sp. type 1 and type 3, IL-12 was associated with goblet cell depletion
23 (85%) (P < 0·001) and 8 (29%) (P = 0·037), respectively. In Blastocystis sp. type 1, low IL-10 was associated with a
proinﬂammatory response characterized by IL-8.
Key words: D-IBS, Blastocystis spp., IL-12, IL-10, TNF-α, IL-8.

INTRODUCTION

Blastocystis spp. is a protozoan parasite commonly
found in the human gastrointestinal tract. The
symptoms attributed to infection with Blastocystis
spp. include diarrhoea, abdominal pain or discomfort, etc. Blastocystis spp. from humans and
animals exhibit similar morphological features.
Extensive genetic variability has been reported in
Blastocystis spp. of both human and animal origin.
A number of molecular techniques used to study
the genetic diversity of Blastocystis spp. include
PCR-restriction fragment length polymorphism
(RFLP) (Abe et al. 2003a, b, c), PCR followed by
dideoxy sequencing (Abe, 2004; Yoshikawa et al.
2004; Stensvold et al. 2006), and PCR with subtypespeciﬁc (sequence-tagged site [STS]) primers (Abe
et al. 2003a, b, c; Khan and Alkhalife, 2005; Yakoob
et al. 2010).
Oral inoculation with 1 × 105 cysts of Blastocystis
sp. strain RN94-9 in rats resulted in chronic infection
in the caecum for 4 weeks after infection (Iguchi et al.
2009). Histological examination revealed only a slight
* Corresponding author: Department of Medicine, Aga
Khan University, PO Box 3500, Stadium Road, Karachi74800, Pakistan. E-mail: yakoobjaved@hotmail.com

increase in goblet cells in the caecal mucosa 1–3 weeks
postinfection but no inﬂammatory cell inﬁltration
nor mucosal sloughing. Signiﬁcant upregulation of
the expression of interferon-γ, IL-12 and TNF-α,
but not IL-6 or granulocyte–macrophage colony
stimulating factor (GM-CSF) was demonstrated in
the caecal mucosa at 2 weeks post-infection. The
induction of local host responses, including mild
goblet cell hyperplasia, and signiﬁcant upregulation
of type-1 and proinﬂammatory cytokines, suggests
that Blastocystis sp. strain RN94-9 is a weakly
pathogenic organism that could elicit proinﬂammatory as well as protective responses in local tissues
(Iguchi et al. 2009). The cysteine proteases of
Blastocystis ratti WR1, a zoonotic isolate, can activate
IL-8 gene expression in human colonic epithelial
cells. The molecular mechanism by which
Blastocystis activates IL-8 gene expression in
human colonic epithelial T84 cells and the production of IL-8 is dependent on NF-κB activation
(Puthia et al. 2008). Previously, an experimental in
vitro study demonstrated Blastocystis spp. is able to
trigger inﬂammatory cytokine response in colonic
epithelial cells (Long et al. 2001). After 24 h
incubation of Blastocystis spp. with the cell lines
HT-29 and T-84, B. hominis cells were not able to
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cause cytopathic eﬀects, but signiﬁcantly increased
the release of IL-8 and GM-CSF. However, after the
ﬁrst 6 h of co-incubation, the production of IL-8 was
not increased in HT-29 cells and even reduced when
Escherichia coli (bacteria or lipopolysaccharide) were
present during co-incubation. Similar eﬀects were
observed using supernatants of Blastocystis spp.
culture. These data indicate that Blastocystis spp.
induces as well as modulates the immune response in
intestinal epithelial cells (Long et al. 2001).
Irritable bowel syndrome (IBS) is common and
has a signiﬁcant medical and socioeconomic impact.
It is considered to be a biopsychosocial disorder
resulting from an interaction among many factors
that included diet, gut microﬂora, visceral hyperalgesia, genetic and environmental factors, infection,
inﬂammation, gut motility and psychological
factors (Drossman et al. 2002). IBS is associated
with abdominal pain or discomfort and an alteration
in bowel habits (Drossman et al. 2002). There has
been a suggestion that some patients with IBS
may harbour bacterial overgrowth leading to lowgrade inﬂammation (O’Leary and Quigley, 2003) and
immune activation (O’Sullivan et al. 2000; Chadwick
et al. 2002), and their symptoms may be ameliorated
by its eradication (Pimentel et al. 2000). Imbalances
in pro- and anti-inﬂammatory cytokine production
may promote ongoing low-grade inﬂammation after
an acute gastroenteritis, and subsequently lead to
IBS (van der Veek et al. 2005). Thus abnormal
neuroimmune interactions may contribute to the
altered gastrointestinal physiology and hypersensitivity that underlies IBS (Barbara et al. 2002).
Previously, we demonstrated that stool culture for
Blastocystis spp. was positive in 46% of the patients
with D-IBS (Yakoob et al. 2004). In the present
study, we determined the cytokine proﬁle in patients
with D-IBS and in those with concomitant
Blastocystis sp. type 1 and 3 infection. We evaluated
cytokine production in vitro from PBMC and
determined tissue cytokine levels of IL-8, IL-10,
IL-12 and TNF-α. IL-12 is a marker of Th1 response
and IL-10 of T regulatory response. The outcome of
an immune response depends on the balance between
pro- and anti-inﬂammatory responses. We aimed
for a comprehensive overview of cytokine proﬁles
including the anti-inﬂammatory cytokine IL-10.

MATERIALS AND METHODS

Study population
This prospective study was conducted at the Aga
Khan University in Karachi, Pakistan. One hundred
and seventy patients with symptoms suggestive of
D-IBS, according to the Rome III criteria, who
attended the gastroenterology clinic from December
2009 to December 2011, were enrolled. Rome III
criteria deﬁne IBS as recurrent abdominal pain or
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discomfort at least 3 days per month in the last
3 months that started at least 6 months before
diagnosis, cannot be explained by a structural or
biochemical abnormality, and is associated with at
least two of the following: improvement with
defecation, onset associated with a change in frequency of stool, and onset associated with a change
in form (appearance) of stool (Drossman and
Dumitrascu, 2006). Other symptoms that support
the diagnosis but are not part of the criteria include
abnormal stool frequency (4 3 bowel movements per
week or >3 bowel movements per day), abnormal
stool form (lumpy/hard or loose/watery), defecation
straining, urgency, or feeling of incomplete bowel
movement, passing mucus and bloating. Four possible IBS subtypes include IBS with constipation
(C-IBS), IBS with diarrhoea (D-IBS), mixed IBS
(M-IBS) and un-subtyped IBS depending on the
predominant stool pattern (Drossman and
Dumitrascu, 2006). Of these ten patients were
excluded; three had coinfection of Giardia lamblia
and one Entameba coli with Blastocystis spp. while
there were 2 each with Blastocystis sp. types 2 and
4 and 1 each with Blastocystis sp. types 5 and 6,
respectively. Forty (25%) were infected with
Blastocystis sp. type 1 and 40 (25%) with
Blastocystis sp. type 3, respectively (Table 2).
Eighty patients with D-IBS and Blastocystis spp.
infection were deﬁned as ‘cases’ and 80 D-IBS
patients without Blastocystis spp. infection were
‘control’ (Table 1). Cases were subdivided into
patients with D-IBS and Blastocystis spp. infection
type 1 or type 3. Standardized subtype-speciﬁc
(STS) primers for Blastocystis sp. subtype 1 (SB83)
and subtype 3 (SB227) deﬁned Blastocystis sp. type 1
and 3. The study was approved by the Ethics
Committee of the Aga Khan University and written
informed consent was obtained from all patients.
After enrolment of eligible patients in the study, a
detailed history and physical examination was carried
out. Colonoscopy of the patient was performed to
rule out any organic disease and four rectal biopsies
were taken, two each for histopathology and cytokine
levels. Blood samples were obtained for cytokines
analysis. Three stool samples collected from each
patient on alternate days were examined by microscopy and cultured for Blastocystis spp. Coeliac
disease, small bowel bacterial overgrowth and lactose
intolerance were excluded by measuring tissue
transglutaminase antibodies (IgA and IgG) and
lactose intolerance by hydrogen breath test, respectively. The inclusion criteria were adults from 18 to 61
years of age with D-IBS, satisfying ROME III
criteria (Drossman and Dumitrascu, 2006).
Exclusion criteria were pregnant and lactating
females, inﬂammatory bowel disease and other
systemic disease, patients on laxatives or antidiarrhoeal drugs that could inﬂuence the motility of
gut, patients on antibiotics that could alter the

Blastocystis spp. associated cytokine immune responses
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Table 1. Comparison of characteristics of controls with and without B. hominis infection

Age (years)
4 35 years
5 36 years
Sex
Male
Female
Symptoms
Abdominal pain
Yes
No
Bloating
Yes
No
Stool frequency
4 4 per day
5 5 or more
Stool microscopy
Positive
Negative
Stool culture
Positive
Negative
Histology
Nonspeciﬁc colitis
Normal
Neutrophil
Absent
Mild
Eosinophil
Absent
Mild
Lymphocyte
Mild
Moderate
Plasma cells
Mild
Moderate
Goblet cell depletion
Absent
Mild
Intraepithelial lymphocyte
Absent
Mild
PBMC cytokines
IL-8
< 12·4 pg mL− 1
5 12·4 pg mL− 1
IL-10
< 15·8 pg mL− 1
5 15·8 pg mL− 1
IL-12
< 5·8 pg mL− 1
5 5·8 pg mL− 1
TNF-α
< 9·3 pg mL− 1
5 9·3 pg mL− 1

Blastocystis hominis
positive, n = 80

Blastocystis hominis
negative, n = 80

33 (41)
47 (59)

32 (40)
48 (60)

0·872

60 (75)
20 (25)

58 (72)
22 (28)

0·719

68 (85)
12 (15)

65 (81)
15 (19)

0·527

55 (69)
25 (31)

53 (66)
27 (34)

0·736

4 (5)
76 (95)

8 (10)
72 (90)

0·369

55 (69)
25 (31)

0 (0)
80 (100)

< 0·001

80 (100)
0 (0)

0 (0)
80 (100)

< 0·001

58 (72)
22 (28)

53 (66)
27 (34)

0·391

50 (63)
30 (37)

38 (47)
42 (53)

0·057

37 (46)
43 (54)

47 (59)
33 (41)

0·113

62 (77)
18 (23)

64 (80)
16 (20)

0·699

62 (77)
18 (23)

58 (72)
22 (28)

0·465

43 (54)
37 (46)

38 (47)
42 (53)

0·429

55 (69)
25 (31)

60 (75)
20 (25)

0·379

45 (56)
35 (44)

31 (39)
49 (61)

0·027

48 (60)
32 (40)

37 (46)
43 (54)

0·081

55 (69)
25 (31)

62 (77)
18 (23)

0·212

28 (35)
52 (65)

32 (40)
48 (60)

0·514

P value
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Table 2A. The sequence-tagged site (STS) primer used

Subtypes

STS
primer
sets

Product
size (bp)

Sequences of forward (F) and
reverse (R) primers (5′ to 3′)

GenBank
accession no.

1

SB83

351

AF166086

2

SB155

650

3

SB227

526

4

SB332

338

5

SB340

704

6

SB336

317

7

SB337

487

F
R
F
R
F
R
F
R
F
R
F
R
F
R

GAAGGACTCTCTGACGATGA
GTCCAAATGAAAGGCAGC
ATCAGCCTACAATCTCCTC
ATCGCCACTTCTCCAAT
TAGGATTTGGTGTTTGGAGA
TTAGAAGTGAAGGAGATGGAAG
GCATCCAGACTACTATCAACATT
CCATTTTCAGACAACCACTTA
TGTTCTTGTGTCTTCTCAGCTC
TTCTTTCACACTCCCGTCAT
GTGGGTAGAGGAAGGAAAACA
AGAACAAGTCGATGAAGTGAGAT
GTCTTTCCCTGTCTATTCTGCA
AATTCGGTCTGCTTCTTCTG

AF166087
AF166088
AF166091
AY048752
AY048751
AY048750

Table 2B. Cytokines primer sequence
Serial no.

Gene

Sequence

1.

IL-12

2.

IL 10

3.

IL-8

4.

TNF-α

5.

GAPDH

5′-CACTCCAGACCCAGGAATGTTC-3′
5′-TTGTCTGGCCTTCTGGAGCAT-3′
5′- ACGGCGCTGTCATCGATT-3′
5′ GGCATTCTTCACCTGCTCCA-3′
5′-ACTGCGCCAACACAGAAATT-3′
5′-TTCTCCACAACCCTCTGCAC-3′
5′-CCCTGGTATGAGCCCATCTATC-3′
5′-AAAGTAGACCTGCCCAGACTCG-3′
5′-GAAGGTGAAGGTCGGAGTC-3′
5′-GAAGATGGTGATGGGATTTC-3′

F
R
F
R
F
R
F
R
F
R

F = Forward primer; R = Reverse primer.
Tsukada et al. (2002).

enteric ﬂora, patients with any ongoing infection,
not willing to participate and those with Blastocystis
spp. infection of more than one genotype. We chose
to study only D-IBS patients as they were more
frequently documented to be positive for Blastocystis
spp. in our patients previously as compared with
other IBS subtypes (Yakoob et al. 2004). The stool
samples from D-IBS patients were screened with the
seven kinds of STS primers 1, 2, 3, 4, 5, 6 and
7. However, we studied only genotypes of Blastocystis
sp. type 1 and 3 which are the predominant types
of Blastocystis spp. identiﬁed among our D-IBS
patients (Yakoob et al. 2010).

Histology
Colonic biopsy specimens were obtained from
rectum at the recto-sigmoid junction and were ﬁxed
immediately in 10% formalin in sodium phosphate
buﬀer and sent to the Department of Pathology for
processing. Biopsies were embedded in paraﬃn, and
histological sections were stained with haematoxylin

and eosin for evaluation. Histological inﬂammation
was graded as 0–3 (0 – nil or without evidence of
histopathology, 1 – mild, 2 – moderate, 3 – severe)
according to the inﬁltration by neutrophils, eosinophils, lymphocytes, plasma cells and epithelial cell
damage e.g. goblet cell depletion, intraepithelial cell
lymphocytes (IEL). The pathologist was blinded to
cytokine data.

Microscopy of fecal smear
Fecal sample microscopy was done as described
before (Zaman and Khan, 1994). Brieﬂy, approximately 2 mg of feces was thoroughly emulsiﬁed on a
glass slide in one drop of physiological saline and
covered with a cover slip. A similar preparation was
made on another slide using Lugol’s iodine. These
preparations were examined under both the low
power (× 10) and high dry (× 40) objectives. Three
fecal samples were examined on alternate days before
giving a negative diagnosis of infection with an
intestinal protozoan.

Blastocystis spp. associated cytokine immune responses

Culture of feces
Blastocystis spp. culture was done by inoculating
approximately 50 mg of feces into Jones’ medium.
Blastocystis spp. culture was performed using Jones
medium without starch (Zaman and Khan, 1994).
The cultures were incubated at 37 °C and examined
after 2–3 days for one week to exclude slow-growing
parasites. The sediment was examined under both
the low power (× 10) and high dry (× 40) objectives.
The positive samples were subcultured for another
3 days using fresh media.
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using Histopaque (Sigma-Aldrich, USA) according
to the density gradient centrifugation method
(Chomczynski and Sacchi, 1987). The collected
PBMCs were washed twice with Roswell Park
Memorial Institute (RPM 1640) culture medium
and resuspended in growth medium of RPMI
supplemented with 10% foetal bovine serum
(FBS), 100 U mL− 1 penicillin-streptomycin and
2·5 μg mL− 1 of fungizone at 37 °C in a CO2 incubator
containing 5% CO2, 95% air and 100% humidity. The
supernatant was removed after 3 days and stored at
−70 °C until further testing.

Extraction of genomic DNA
Genomic DNA of Blastocystis spp. was extracted
by using a Stool DNA Extraction kit (Qiagen)
according to the manufacturer’s protocol. Extracted
DNA was stored at − 20 °C until PCR was carried
out for Blastocystis spp. genotyping.
Blastocystis spp. genotyping by PCR with STS primers
Seven kinds of STS primers developed for typing
the Blastocystis spp. isolates were used as described
previously (Table 2A) (Yoshikawa et al. 1998,
2000, 2003; Abe et al. 2003a, b; Yan et al. 2006;
Li et al. 2007a, b). Seven standardized subtypespeciﬁc STS primers were used, namely SB83
(351 bp) for subtype 1, SB340 (704 bp) for subtype
2, SB227 (526 bp) for subtype 3, SB337 (487 bp)
for subtype 4, SB336 (317 bp) for subtype 5,
SB332 (338 bp) for subtype 6, and SB155 (650 bp)
for subtype 7 according to a recent classiﬁcation
terminology (Stensvold et al. 2007). Typing of the
Blastocystis spp. isolates was conducted through PCR
ampliﬁcation on the basis of the presence or absence
of the products with parallel control. The PCR
conditions consisted of one cycle denaturing at 94 °C
for 3 min, 30 cycles including annealing at 59 °C for
30 s, extending at 72 °C for 60 s, denaturing at 94 °C
for 30 s, and additional cycle with a 5-min chain
elongation at 72 °C (PCR System 9700, Perkin
Elmer, USA). The PCR products and molecular
markers were electrophoresed in 2% agarose gel with
Tris-acetate-EDTA electrophoresis buﬀer. The size
markers were 100-bp ladder (Promega, USA). The
PCR ampliﬁcation for each primer pair was repeated
at least thrice. Bands were visualized by the imaging
system (Gel Doc 2000, Gel Documentation System,
Bio-Rad, UK) after being stained with ethidium
bromide.
Isolation of peripheral blood mononuclear cells
Blood samples from patients with D-IBS (approximately 4 mL) were collected in sterile ethylene
diaminetetra-acetate (EDTA) containing tubes.
Peripheral blood mononuclear cells were isolated

Cytokine assays
Cell culture supernatants were harvested and analysed for cytokines by ELISA techniques with
commercially available kits. Human IL-8, 10, 12
and TNF-α kits were obtained from BD OptEIA. All
cytokine assays were calibrated against the World
Health Organization international standards by the
kit manufacturer. The lower limits of detection
for the individual assays are as follows: IL-8,
0·8 pg mL− 1; IL-10, 2 pg mL− 1; IL-12, 4 pg mL− 1
and TNF-α, 2 pg mL− 1.

Biopsy cytokines using real-time quantitative
PCR with SYBR Green
TRIzol. Intestinal biopsy specimens obtained
for RNA extraction were collected in an Eppendorf
vial containing TRIzols Reagent (Invitrogen
Corporation, USA) and stored in a liquid nitrogen
container for transport to the laboratory and stored at
−70 °C until further use. Total RNA was extracted
from endoscopic biopsy samples of colonic mucosa
with TRIzol method described previously. Reverse
transcription of the extracted RNA was performed
using RNase H-deﬁcient reverse transcriptase
(Superscript II, Life Technologies) and oligo (dT)
primers (Life Technologies). Aliquots (2 μL) of
reverse transcription reaction mixture (20 μL) were
used for quantitation of IL-12, IL 10, IL-8 TNF-α
and GAPDH gene expression by real-time PCR
assays (Table 2B) (Tsukada et al. 2002). The SYBR
Green QRT PCR was used to quantify IL-12, IL-10,
IL-8, TNF-α and GAPDH gene expression (PE
Applied Biosystems, Foster City, CA). The PCR
reactions were performed using the SYBR Green
QRT PCR kit (PE Applied Biosystems) as described
previously (Heid et al. 1996). After activation for
10 min at 95 °C, 40 cycles of 15 s at 95 °C and 1 min
at 62 °C was carried out in model icycler (Biorad).
Real-time ﬂuorescence measurements was recorded
and the threshold cycle (Ct) value for each sample
calculated by the above sequence detector (Heid et al.
1996). For IL-12, TNF-α and GAPDH standard
curves of Ct values were obtained from real-time
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Fig. 1. Comparison of PBMC cytokines with Blastocystis sp. type 1 and 3 and control.

PCR of pMFGhTNF, pBSKIhIL-12 and PCRII
GAPDH (Reference plasmids). The relative fold
change in mRNA expression of the target gene was
calculated with 2− ∆∆CT method using the software
GENEX. The 2− ∆∆CT method presents the data as
fold change in mRNA expression of the target gene,
normalized to the mRNA expression of the housekeeping gene. Glyceraldehyde-3-phosphate dehydrogenase was used as the housekeeping gene in
all the QRT-PCR experiment. Each biopsy sample
obtained from the same patient was tested in
duplicate, and the average of two Ct values was
used in this study.

were two sided. Statistical interpretation of data was
performed by using the computerized software
program SPSS version 19.

RESULTS

Ninety-ﬁve (59%) of the patients were over 35 years of
age. Abdominal pain, bloating and frequency of stool
were equally common in both groups (Table 1). Fecal
smear microscopy for Blastocystis spp. was positive
in 55 (69%) and Blastocystis spp. culture was positive
in 80 (50%) (Table 1).

Blastocystis spp. subtypes and histology
Statistical methods
Results are expressed as mean ± S.D. for continuous
normally distributed variables whereas median with
IQR (interquartile range) for non-normal variables
and number (percentage) for categorical data.
Diﬀerences in mean comparison of characteristics of
IBS patients with and without Blastocystis sp.
infection type-I and 3 with control group for
normally distributed variables were performed by
using the analysis of variance (ANOVA) and Tukey’s
HSD test was used for multiple comparison, however
for non-normal variables a non-parametric Kruskal–
Wallis test and Mann–Whitney test were used for
within-group comparison. Diﬀerences in proportion
were compared by Pearson Chi-square or Fisher
exact where appropriate. A P value of <0·05 was
considered as statistically signiﬁcant. All P values

Non-speciﬁc colitis was present in 58 (72%) with
Blastocystis spp. infection and in 53 (66%) without
(P = 0·391) (Table 1). Of the 58 Blastocystis positive
D-IBS with non-speciﬁc colitis, Blastocystis sp.
subtype 1 was 30 (75%) compared with control of
53 (66%) (P = 0·328) and Blastocystis sp. subtype 3
was 28 (70%) compared with control of 53 (66%)
(P = 0·679). There was no signiﬁcant diﬀerence
in the distribution of neutrophils, eosinophils,
mononuclear cells or evidence of epithelial cell
damage in the colonic mucosal biopsies in the two
groups (Table 1).

Blastocystis spp. types and PBMC cytokines
Patients with D-IBS infected with Blastocystis
spp. demonstrated low PBMC production of IL-8 in

Control,
n = 80

B. hominis Type 3,
n = 40

Control,
n = 80

18 (45)
22 (55)

32 (40)
48 (60)

0·600

15 (37)
25 (63)

32 (40)
48 (60)

0·791

28 (70)
12 (30)

58 (73)
22 (27)

0·774

32 (80)
8 (20)

58 (72)
22 (28)

0·371

28 (70)
12 (30)

65 (81)
15 (19)

0·164

35 (87)
5 (13)

65 (81)
15 (19)

0·386

23 (57)
17 (43)

53 (66)
27 (34)

0·348

32 (80)
8 (20)

53 (66)
27 (34)

0·118

4 (10)
36 (90)

8 (9)
72 (91)

0·999

6 (15)
34 (85)

8 (10)
72 (90)

0·421

30 (75)
10 (25)

0 (0)
80 (100)

< 0·001

25 (62)
15 (38)

0 (0)
80 (100)

< 0·001

40 (100)
0 (0)

0 (0)
80 (100)

< 0·001

40 (100)
0 (0)

0 (0)
80 (100)

< 0·001

30 (75)
10 (25)

53 (66)
27 (34)

0·328

28 (70)
12 (30)

53 (66)
27 (34)

0·679

26 (65)
14 (35)

38 (47)
42 (53)

0·070

24 (60)
16 (40)

38 (47)
42 (53)

0·196

17 (42)
23 (58)

47 (59)
33 (41)

0·093

20 (50)
20 (50)

47 (59)
33 (41)

0·363

25 (63)
15 (37)

64 (80)
16 (20)

0·039

28 (70)
12 (30)

64 (80)
16 (20)

0·222

30 (75)
10 (25)

58 (73)
22 (27)

0·770

32 (80)
8 (20)

58 (73)
22 (27)

0·371

27 (67)
13 (33)

38 (47)
42 (53)

0·038

16 (40)
24 (60)

38 (48)
42 (52)

0·436

23 (57)
17 (43)

60 (75)
20 (25)

0·050

32 (80)
8 (20)

60 (75)
20 (25)

0·542

P value

P value

963

Age (years)
4 35 years
5 36 years
Gender
Male
Female
Abdominal pain
Yes
No
Bloating
Yes
No
Stool frequency
4 4 per day
5 5 per day
Stool microscopy
Positive
Negative
Stool culture
Positive
Negative
Histology
Nonspeciﬁc colitis
Normal
Neutrophil
Absent
Mild
Eosinophil
Absent
Mild
Lymphocyte
Mild
Moderate
Plasma cells
Mild
Moderate
Goblet cell depletion
Absent
Mild
Intraepithelial
lymphocyte
Absent
Mild

B. hominis Type 1,
n = 40
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Table 3. Comparison of characteristics of controls with B. hominis type genotype

Javed Yakoob and others

964

Table 4. Comparison of peripheral cytokines with B. hominis types and control
P value

Blood IL-8

Blood IL-10

Blood IL-12

Blood TNF-α

BH type1 (n = 40)
BH type 3 (n = 40)
Control (n = 80)
BH type1 (n = 40)
BH type 3 (n = 40)
Control (n = 80)
BH type1 (n = 40)
BH type 3 (n = 40)
Control (n = 42)
BH type1 (n = 40)
BH type 3 (n = 40)
Control (n = 82)

Mean ± S.D.

Over all

B hominis
type 1 vs 3

B hominis
type 1 vs control

B hominis
type 3 vs control

12·3 ± 4·5
12·2 ± 3·5
12·5 ± 4
14·5 ± 1·6
16·7 ± 1·5
16·0 ± 2·3
5·0 ± 1
5·2 ± 1
5·2 ± 1
10·4 ± 4·0
9·5 ± 3·2
8·5 ± 4·5

0·929

NS

NS

NS

< 0·001*

< 0·001*

< 0·001*

0·786

NS

NS

NS

0·051

NS

0·054

NS

0·367

* P value <0·05 was considered as statistically signiﬁcant; NS = not signiﬁcant; S.D. = Std. deviation.

Fig. 2. Comparison of cytokine mRNA expression in colonic mucosa between B. hominis subtypes and control group.

45 (56%) (P = 0·027) compared with control 31 (39%)
(Table 1). There was no diﬀerence in the PBMC
production of IL-10, IL-12 and TNF-α by PBMCs in
vitro in the Blastocystis spp. infected and control
groups (Table 1). Patients with D-IBS infected with
Blastocystis sp. type 1 demonstrated low PBMC production of IL-10 in 36 (90%) compared with control
37 (46%) (P < 0·001) (Fig. 1). The mean concentration
of IL-10 (14·5 ± 1·6 pg mL− 1, P < 0·001) was low in
Blastocystis sp. type 1 compared with those with
Blastocystis sp. type 3 (16·7 ± 1·5 pg mL− 1) and
controls (16 ± 2·3 pg mL− 1) (Table 4), and these
diﬀerences remained signiﬁcant after adjustment

for multiple comparisons, P < 0·001 and P < 0·001,
respectively (Table 4).
Comparison between Blastocystis spp. types with
PBMC expressed cytokines and histology
In Blastocystis sp. type 1, mucosal lymphocyte and
IEL inﬁltration were 15 (37%) (P = 0·039) and 17 (43)
(P = 0·050), respectively compared with control of
16 (20%) and 20 (25%) (Table 3). In Blastocystis sp.
type 1, IL-8 was associated with mild eosinophil
inﬁltration in 18 (72%) (P = 0·024); IL-10 with
lymphocyte in 25 (69%) (P = 0·015), plasma cell

Blastocystis spp. associated cytokine immune responses

Fig. 3. Colonic glands showing intraepithelial
lymphocytes in the glandular lining epithelium. H&E
× 10.

inﬁltration in 30 (83%) (P = 0·002) and IEL in 23
(64%) (P = 0·026) (Figs 3–5); IL-12 was associated
with goblet cell depletion in 13 (100%) (P < 0·001)
and IEL in 9 (69%) (P = 0·038) and TNF-α also with
plasma cell inﬁltration in 12 (100%) (P = 0·019)
(Table 5). In Blastocystis sp. type 3, IL-8 was
associated with goblet cell depletion in 16 (80%)
(P = 0·010) and IEL in 8 (40%) (P = 0·003); IL-10 in
above mean values with mild lymphocyte in 24 (86%)
(P = 0·002) and plasma cell inﬁltration in 28 (100%)
(P < 0·001); IL-12 was associated with goblet cell
depletion in 20 (71%) (P = 0·037) and TNF-α was
associated with lymphocyte in 12 (50%) (P = 0·001)
and plasma cell inﬁltration in 8 (33%) (P = 0·013)
(Table 5).

Comparison between Blastocystis spp. types and
cytokine mRNA expression in colonic mucosa
The expression of IL-8 mRNA (pg mL− 1) in colonic
mucosa in Blastocystis sp. type 1 (median with
interquartile range) was 3·4 (1·04–7·30), type 3 was
1·2 (0·21–2·14) and for control was 1 (0·27–9·8)
(P = 0·016). The expression of IL-10 mRNA
(pg mL− 1) in colonic mucosa in Blastocystis sp.
type 1was 0·78 (0·34–5·7), type 3 was 1 (0·97–0·99)
and for control was 0·27 (0·04–3·6) (P = 0·153). The
expression of IL-12 mRNA (pg mL− 1) in colonic
mucosa in Blastocystis sp. type 1 was 1·5 (1·2–5·15),
type 3 was 2 (0·22–7·06) and for control was 1
(2·1–13·8) (P = 0·005). The expression of TNF-α
mRNA (pg mL− 1) in colonic mucosa in Blastocystis
sp. type 1 was 0·54 (0·05–1·5), type 3 was 0·87
(0·53–1·8) and for control was 6·7 (2·03–14·7)
(P < 0·001). The IL-8mRNA expression was increased in Blastocystis sp. type 1 compared with type
3 (P = 0·001) and control (P = 0·001) (Fig. 2). The
expression of mRNA of IL-10 was low in the control
group and Blastocystis sp. type 3 and type 1 (Fig. 2).
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Fig. 4. Colonic glands showing intraepithelial
lymphocytes in the glandular lining epithelium H&E
× 20.

Fig. 5. Colonic glands showing mucin (goblet cell)
depletion. H&E × 20.

The IL-10 mRNA expression was increased in
Blastocystis sp. type 1 compared with control
(P = 0·016) (Fig. 2). The expression of mRNA of
IL-12 was higher in the control group compared with
Blastocystis sp. type 3 and type 1 (P < 0·001 and 0·005,
respectively) (Fig. 2). The expression of mRNA of
TNF-α was higher in the control group compared
with Blastocystis sp. type 3 and type 1 (P = < 0·001
and 0·001, respectively) (Fig. 2).
DISCUSSION

Blastocystis spp. is an extracellular luminal organism.
It is able to evade the host immune response by
suppressing iNoS production and cleaving immunoglobulin (Puthia et al. 2005; Mirza et al. 2011). This
may also compromise these protective responses to
other coinfecting pathogens allowing them to infect
host epithelia and cause disease. There have been
studies investigating the priming of human immune
responses by intestinal protozoa (Djuardi et al. 2010).
The presence of Blastocystis spp. as the predominant
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Table 5. Comparison between B. hominis types, peripheral blood mononuclear cells cytokines and histological parameters
IL8

B. Hominis
TYPE 1

Lymphocyte
Grade
Plasma cell
Grade
Neutrophil
Grade
Eosinophil
Grade

B. Hominis
TYPE 3

IL-10

IL-12

TNF

< 12·4 pg
mL− 1

5 12·4 pg
mL− 1

Mild
Moderate

15 (60)
10 (40)

10 (67)
5 (33)

0·673

25 (69)
11 (31)

0
4 (100)

0·015

16 (59)
11 (41)

9 (69)
4 (31)

0·542

9 (75)
3 (25)

16 (57)
12 (43)

0·477

Mild
Moderate

19 (76)
6 (24)

11 (73)
4 (27)

0·850

30 (83)
6 (17)

0
4 (100)

0·002

19 (70)
8 (30)

11 (85)
2 (15)

0·451

12 (100)
0 (0)

18 (64)
10 (36)

0·019

Absent
Mild

18 (72)
7 (28)

8 (53)
7 (47)

0·231

22 (61)
14 (39)

4 (100)
0

0·278

18 (67)
9 (33)

8 (61)
5 (39)

1

6 (50)
6 (50)

20 (71)
8 (29)

0·193

10 (67)
5 (33)

0·024

17 (47)
19 (53)

0
4 (100)

0·123

10 (37)
17 (63)

7 (54)
6 (46)

0·314

7 (58)
5 (42)

10 (36)
18 (64)

0·185

11 (73)
4 (27)

0·117

19 (53)
17 (47)

4 (100)
0

0·123

23 (85)
4 (15)

0 (0) < 0·001
13 (100)

3 (25)
9 (75)

20 (71)
8 (29)

0·013

11 (73)
4 (27)

0·187

23 (64)
13 (36)

0
4 (100)

0·026

19 (70)
8 (30)

4 (31)
9 (69)

0·038

7 (58)
5 (42)

16 (57)
12 (43)

0·944

12 (60)
8 (40)

0·168

4 (33)
8 (67)

24 (86)
4 (14)

0·002

16 (57)
12 (43)

12 (100)
0 (0)

0·007

16 (100)
0

12 (50)
12 (50)

0·001

16 (80)
4 (20)

0·999

4 (33)
8 (67)

28 (100)
0

< 0·001

20 (71)
8 (29)

12 (100)
0 (0)

0·079

16 (100)
0

16 (67)
8 (33)

0·013

12 (60)
8 (40)

0·999

4 (33)
8 (67)

20 (71)
8 (29)

0·037

16 (57)
12 (43)

8 (67)
4 (33)

0·729

12 (75)
4 (25)

12 (50)
12 (50)

0·144

8 (40)
12 (60)

0·206

8 (67)
4 (33)

12 (43)
16 (57)

0·301

16 (57)
12 (33)

4 (33)
8 (67)

0·301

8 (50)
8 (50)

12 (50)
12 (50)

0·999

4 (20)
16 (80)

0·010

4 (33)
8 (67)

12 (43)
16 (57)

0·729

8 (29)
20 (71)

8 (67)
4 (33)

0·037

8 (50)
8 (50)

8 (33)
16 (67)

0·292

12 (60)
8 (40)

0·003

8 (67)
4 (33)

24 (86)
4 (14)

0·211

24 (86)
4 (14)

8 (67)
4 (33)

0·211

16 (100)
0

16 (67)
8 (33)

0·013

< 15·8 pg
mL− 1

< 15·8 pg
mL

P

< 5·2 pg
mL

< 5·2 pg
mL− 1

P

< 9·3 pg
mL− 1

5 9·3 pg
mL

P
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Absent
7 (28)
Mild
18 (72)
Goblet cell depletion
Grade
Absent
12 (48)
Mild
13 (52)
Intra-epithelial cell
Grade
Absent
12 (48)
Mild
13 (52)
Lymphocyte
Grade
Mild
16 (80)
Moderate
4 (20)
Plasma cell
Grade
Mild
16 (80)
Moderate
4 (20)
Neutrophil
Grade
Absent
12 (60)
Mild
8 (40)
Eosinophil
Grade
Absent
12 (60)
Mild
8 (40)
Goblet cell depletion
Grade
Absent
12 (60)
Mild
8 (40)
Intra Epithelial cell lymphocyte
Grade
Absent
20 (100)
Mild
0

P

0·292
34 (71)
14 (29)
26 (81)
6 (19)
1
14 (78)
4 (22)
46 (74)
16 (26)
0·154
35 (81)
8 (19)
0·895
37 (75)
12 (25)

25 (68)
12 (32)

0·001
30 (62)
18 (38)
8 (25)
24 (75)
0·015
4 (22)
14 (78)
34 (55)
28 (45)
0·012
12 (32)
25 (68)
0·002
30 (61)
19 (39)

26 (61)
17 (39)

0·578
27 (56)
21 (44)
20 (62)
12 (38)
0·003
16 (89)
2 (11)
31 (50)
31 (50)
0·212
28 (65)
15 (35)
19 (51)
18 (49)
< 0·001
20 (41)
29 (59)

Mild
27 (87)
Moderate
4 (13)
Goblet cell depletion
Grade
Mild
8 (26)
Moderate
23 (74)
Intra epithelial cell lymphocyte
Grade
Mild
23 (74)
Moderate
8 (26)

Eosinophil
Grade

0·715
22 (46)
26 (54)
16 (50)
16 (50)
0·064
12 (67)
6 (33)
26 (42)
36 (58)
0·012
26 (60)
17 (40)
12(32)
25 (68)
0·015
18(35)
31 (65)
20 (64)
11 (35)
Mild
Moderate
Neutrophil
Grade

0·683
34 (71)
14 (29)
24 (75)
8 (25)
0·132
16 (89)
2 (11)
42 (68)
20 (32)
0·055
35 (81)
8 (19)
23 (60)
14 (40)
0·020
31 (63)
18 (37)
27 (87)
4 (13)
Mild
Moderate
Plasma cell
Grade

Histological inﬂammation was graded as 0 = nil, 1 = mild, 2 = moderate, 3 = severe.

B. Hominis
non
infective

Lymphocyte
Grade

Mild
Moderate

27 (87)
4 (13)

37 (76)
12 (24)

0·260

25 (68)
12 (32)

39 (91)
4 (9)

0·010

46 (74)
16 (26)

18 (100)
0 (0)

0·017

24 (75)
8 (25)

40 (83)
8 (17)

0·361
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species in pregnant mothers was shown to dampen
the innate and adaptive responses to puriﬁed protein
derivative (PPD) of mycobacterium tuberculosis
(Djuardi et al. 2010). Earlier studies have shown
that Blastocystis spp. infection can be associated with
impaired intestinal permeability (Mirza et al. 2012)
as well as lower total leucocyte and neutrophil count
(Reiman et al. 2006).
In this study, colonoscopic examination of
D-IBS patients with Blastocystis spp. demonstrated
no pathological changes or only non-speciﬁc inﬂammation without evidence of invasion with
Blastocystis spp., in keeping with previous studies
(Chen et al. 2005). Also, Blastocystis strain RN94-9
induced neither epithelial injury nor inﬂammatory
cell inﬁltration in rat caecal mucosa (Iguchi et al.
2009). The non-invasive nature of strain RN94-9 was
further conﬁrmed by normal expression levels of
epithelial tight junction proteins. In D-IBS with
Blastocystis spp. infection, PBMCs IL-8 and IL-10
responses were less marked in Blastocystis sp. type 1
compared with control (Table 3). The mean IL-10
was signiﬁcantly lower in Blastocystis sp. type 1
compared with Blastocystis sp. type 3 and control
(Table 4). In Blastocystis sp. type 1, there was colonic
mucosal eosinophil inﬁltration associated with IL-8
compared with Blastocystis sp. type 3 (Table 5) and
lymphocyte inﬁltration and goblet cell depletion
compared with control (Table 3). In contrast, in a
mouse model of Blastocystis spp. infection (Iguchi
et al. 2009) goblet cell hyperplasia was reported.
Moreover, goblet cell hyperplasia has also been
reported in Giardia infections as well (PonceMacotela et al. 2008). It is known that T helper
type 2 cytokines (IL-13 and IL-4) regulate the
development of goblet cell hyperplasia in the gut
during infection and an increased number of goblet
cells plays an important role in host protective
immunity against infection (Khan and Alkhalife,
2005). Goblet cell hyperplasia, increased mucin and
ﬂuid secretion and enhanced intestinal propulsive
activity results in the eviction of noxious agents from
the gut lumen. However, a single administration of
recombinant adenovirus vector expressing IL-12
(Ad5IL-12) in Trichinella spiralis-infected mice
inhibited infection-induced muscle hypercontractility and goblet cell hyperplasia. This also correlated
with upregulated interferon-γ (IFN-γ) expression
and downregulated IL-13 expression in the muscularis externa layer (Khan et al. 2001). These results
indicate that transfer and overexpression of the IL-12
gene during Th2-based infection shifts the immune
response towards Th1 and abrogates the physiological responses to infection, attenuating both muscle
hypercontractility and goblet cell hyperplasia
(Khan et al. 2001). O’Malley et al. (2010) reported
goblet cell hyperplasia in a rat model of anxiety
and depression. The ﬁnding of goblet cell
depletion in both case and control in this study is
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surprising and may be explained on the basis that
Th2 reaction when replaced by a proinﬂammatory
reaction leads to goblet cell depletion in D-IBS in
humans.
IL-12 plays a key role in induction of Th1 immune
responses by stimulating the production of IFN-γ
and TNF-α from T and natural killer (NK) cells. In
this study, IL 12 was associated with goblet cell
depletion in both cases and control (Table 5). Long
et al. (2001) in an in vitro study reported Blastocystis
sp. type 1 elicited a signiﬁcant increase in proinﬂammatory IL-8 in HT-29 and T-84 IEC human colonic
cell lines. This was observable after 24 h exposure to
parasites (Long et al. 2001). However, the PBMCs
culture supernatants harvested after 72 h of incubation did not show signiﬁcant cytokine variation
among Blastocystis spp. types and control (Tables 4
and 5). It has been previously reported that cytokine
changes presented within 6 h (Long et al. 2001) and
normalized after that period. IL-10, having a
regulatory role, is produced by activated lymphocytes
in later phases of the immune response (Schröder
et al. 1987; De Waal Malefyt et al. 1991). The antiinﬂammatory cytokine IL-10 inhibits monocytes
production of pro-inﬂammatory cytokines including
TNF-α which subsequently regulates both early
neutrophilic inﬁltration and eosinophil recruitment
(Asseman et al. 1999). Secretion of IL-10 is also
induced by TNF-α linking its production to inﬂammation (Powrie et al. 1994). In Blastocystis spp.
type 1 and type 3, IL-12 and TNF-α mRNAs
expression were also low compared with in control
(Fig. 2). The low IL-12 and TNF-α in coinfection
with Blastocystis spp. may be attributed to the
immune modifying eﬀect of Blastocystis spp.
Previously, the downregulation of IFN-γ and
TNF-α together with the upregulation of IL-6,
IL-8, as well as NF-κB gene expressions were seen
in the PBMCs stimulated with 1 μg mL− 1 of
Blastocystis antigen. This suggested that Blastocystis
antigen stimulated the humoral immune responses in
PBMCs, which may lead to inﬂammatory reactions
and propagation of the cells to combat the infection
(Chandramathi et al. 2010).
IL-10 is important in regulating inﬂammatory
response as it reduces the production of chemotactic
factors, such as IL-8 (Turner et al. 1997; Olivo-Diaz
et al. 2012). Previously in animal models, gene
transcription of type 1 and proinﬂammatory cytokines IFN-γ, IL-12 and TNF-α was signiﬁcantly
upregulated in the caecal mucosa. These results
suggest that Blastocystis infection in rats induces
local host responses to exposed antigens (Iguchi
et al. 2009). In D-IBS with Blastocystis spp., the
IL-8mRNA expression was increased in Blastocystis
sp. type 1 compared with type 3 (P = 0·001) and
control (P = 0·001) (Fig. 2). In keeping with the
previous studies that showed Blastocystis strains N
and II that belong to subtype 1 and WR1 belonging
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to subtype 4 stimulated the release of chemokine
IL-8 from a human colonic epithelial cell line in vitro,
possibly mediated by the organism-derived cysteine
protease (Long et al. 2001; Puthia et al. 2005).
Blastocystosis may not be a highly inﬂammatory
disease (at least in the context of these isolates)
as evidenced by low levels of cytokine among
Blastocystis spp. types and control. The severity of
Blastocystosis spp. infection may be mediated by host
factors. Secretion of high levels of enteric antiBlastocystis IgA has been found to be a common
factor in all symptomatic, but not asymptomatic,
cases of Blastocystis (Mahmoud and Saleh, 2003).
This would also explain why some individuals can
be carriers of the organism without expressing
symptoms (Markell and Udkow, 1986).
The limitation of this study is that the case-tocontrol patient ratio of 1:1 is too small to draw any
ﬁrm conclusion. A case-to-control ratio of 2:1 or 3:1
would have been preferable. The size of the case
group was limited by the number of eligible patients
fulﬁlling the Rome III criteria for D-IBS infected
with Blastocystis sp. subtype 1 or 3 and the resources
required for experiments on this sample size. In
conclusion, in patients with D-IBS and concomitant
Blastocystis sp. type 1 infection, there is a low IL10
response compared with type 3 and D-IBS without
Blastocystis spp. and this may be attributable to an
immune modifying eﬀect of Blastocystis sp. infection
in D-IBS.
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